Table 2 Metabolic syndrome prevalence by different breast cancer subtypes among postmenopausal women
From: Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
MS prevalence | OR | p | |
|---|---|---|---|
LUMINAL (Luminal A + Luminal B) | 62.7% | 1.37(1.07-2.80) | 0.03 |
LUMINAL A | 25.5% | 0.71 (0.41-1.21) | 0.2 |
LUMINAL B | 37.5% | 1.74 (0.99-3.06) | 0.06 |
HER-2+ | 20% | 0.60 (0.19-1.86) | 0.38 |
TN | 25.8% | 0.85 (0.36-1.0) | 0.71 |